1-4 of 4
Gregory J Cost, PhD
Close
Sort by
Journal Articles

Genome Editing Via NHEJ-Mediated Targeted Integration Retains Engraftment Potential of Edited Hematopoietic Stem Cells

Gene I. Uenishi, PhD, Keith Abe, Bee-Chun Sun, Cornell Mallari, Andrew M. Scharenberg, MD, Gregory J. Cost, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3480.
https://doi.org/10.1182/blood-2018-99-117488
Published: 2018
Journal Articles

Chemically Controlled, Immunosuppression-Resistant, Anti-Bcma CAR-T Cells for Treatment of Antibody-Mediated Autoimmunity

Sowndharya Rajavel, Cade E. Ito, Keith Abe, Valerie Guerrero, Gene I. Uenishi, PhD, Andrew M. Scharenberg, MD, Gregory J. Cost, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2203.
https://doi.org/10.1182/blood-2018-99-117630
Published: 2018
Journal Articles

Preservation of Gene Edited Hematopoietic Stem Cells By Transient Overexpression of BCL-2 mRNA

Carmen Flores Bjurström, PhD, Michelle Mojadidi, MSc, Anastasia Lomova, BS, Stephen Lai, Sorel Fitz-Gibbon, PhD, Matteo Pellegrini, PhD, Aaron R Cooper, PhD, Georgia R Lill, MSc, Michael Kaufman, MSc, Gregory J Cost, PhD, Michael C. Holmes, PhD, Roger P Hollis, PhD, Donald B Kohn
Journal: Blood
Blood (2016) 128 (22): 3636.
https://doi.org/10.1182/blood.V128.22.3636.3636
Published: 2016
Journal Articles

HPRT As a Selectable Safe Harbor for Transgenesis

Anthony Conway, PhD, Josée Laganière, PhD, David E Paschon, PhD, Katrin Hacke, PhD, Noriyuki Kasahara, MD PhD, Philip D Gregory, PhD, Michael C. Holmes, PhD, Gregory J Cost, PhD
Journal: Blood
Blood (2014) 124 (21): 4796.
https://doi.org/10.1182/blood.V124.21.4796.4796
Published: 2014